DOCSLIB.ORG

Genome-Wide Analysis of Histone Marks Identifying an Epigenetic Signature of Promoters and Enhancers Underlying Cardiac Hypertrophy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genome-Wide Analysis of Histone Marks Identifying an Epigenetic Signature of Promoters and Enhancers Underlying Cardiac Hypertrophy Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy Roberto Papaita,b,1, Paola Cattaneoa, Paolo Kunderfrancoa, Carolina Grecoa, Pierluigi Carulloa,b, Alessandro Guffantic, Valentina Viganòc, Giuliano Giuseppe Stirparoa,d, Michael V. G. Latronicoa, Gerd Hasenfusse, Ju Chenf, and Gianluigi Condorellia,d,1 aHumanitas Clinical and Research Center, 20089 Rozzano, Italy; bInstitute of Genetics and Biomedical Research, National Research Council of Italy, 20098 Rozzano, Italy; cGenomnia srl, 20020 Lainate, Italy; dUniversity of Milan, 20098 Milan, Italy; eDepartment of Cardiology and Pneumology, Georg-August University, 37075 Göttingen, Germany; and fDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093 Edited by Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX, and approved November 4, 2013 (received for review August 13, 2013) Cardiac hypertrophy, initially an adaptive response of the myo- Hitherto, most research on the epigenetics of heart failure has cardium to stress, can progress to heart failure. The epigenetic focused on the role of histone deacetylases (HDACs; e.g., HDAC5, signature underlying this phenomenon is poorly understood. Here, HDAC9, and HDAC2) and histone acetyl transferases (HATs; we report on the genome-wide distribution of seven histone mod- e.g., p300). These studies demonstrated a key role for these ifications in adult mouse cardiomyocytes subjected to a prohyper- enzymes in the cardiac hypertrophy program and, thus, suggest a trophy stimulus in vivo. We found a set of promoters with an role for histone acetylation in triggering the transcriptional changes epigenetic pattern that distinguishes specific functional classes occurring in cardiac hypertrophy and heart failure (11–14). How- fi of genes regulated in hypertrophy and identi ed 9,207 candidate ever, we still do not know which genes are regulated by histone active enhancers whose activity was modulated. We also analyzed modifications or how histone modifications influence transcrip- the transcriptional network within which these genetic elements fi tion in cardiac hypertrophy. act to orchestrate hypertrophy gene expression, nding a role Here, we describe epigenetic changes occurring in adult for myocyte enhancer factor (MEF)2C and MEF2A in regulating mouse cardiomyocytes subjected to a prohypertrophy stimulus enhancers. We propose that the epigenetic landscape is a key in vivo. determinant of gene expression reprogramming in cardiac hy- pertrophy and provide a basis for understanding the role of Results chromatin in regulating this phenomenon. Epigenetic Profile Changes in Hypertrophic Cardiomyocytes. To gain insight into the role epigenetics plays in heart failure, we gen- epigenetic regulation | histone acetylation | histone methylation erated genome-wide chromatin-state maps for normal and hy- pertrophic cardiomyocytes and compared them with the gene eart failure, a leading cause of mortality worldwide, is fre- expression profiles of those cells (Fig. 1A). To this end, we Hquently accompanied by cardiac hypertrophy, a process performed chromatin immunoprecipitation (ChIP) coupled with characterized by the expression of genes normally present during massively parallel DNA sequencing (ChIP-seq) on cardiomyocytes the fetal stage and the repression of certain genes expressed in isolated from the left ventricle of mice that had been subjected adults (1, 2). Although epigenetics is important in regulating to transverse aortic constriction (TAC), a surgical procedure that transcription, our understanding of its role in cardiac hypertro- phy remains scant (3). fi Histone marks, such as acetylation (ac) and methylation (me) Signi cance of lysine (K) residues of histone H3, play an important role in regulating transcription. Combinations of these marks create an Cardiac failure is a leading cause of mortality worldwide and “epigenetic code” that defines the transcriptional status of genes: a major financial burden for healthcare systems. New tools for high levels of monoacetylated (ac) Lys-9 and Lys-14 (H3K9ac understanding cardiovascular disease and developing better and H3K14ac) and trimethylated (me3) Lys-4 (H3K4me3) in therapeutic approaches are therefore needed. To this end, promoter regions, and trimethylated Lys-36 (H3K36me3) and di- transcriptional regulation has been extensively studied in car- methylated (me2) Lys-79 (H3K79me2) in the body of genes, are diac hypertrophy and failure, but there is still a lack of un- detected in transcriptionally active regions. In contrast, an ele- derstanding of the epigenetic framework in which transcrip- vated level of deacetylated histones and histone H3 trimethy- tion factors act. Our report adds significant knowledge to the lated on Lys-9 and Lys-27 (H3K9me3 and H3K27me3) are field because we demonstrate, in vivo, that a complex and associated with inactive regions (4–7). specific epigenetic signature regulates gene expression by Histone modifications also influence the activity of enhancers modulating promoters and enhancers, a large number of which involved in regulating gene expression during development and have been described here. These findings advance our un- cell differentiation. In human embryonic stem cells, specific derstanding of the mechanisms underlying this pathology. epigenetic signatures define the activity of enhancer elements involved in the early stages of embryogenesis: H3K27ac is a Author contributions: R.P. and G.C. designed research; R.P., P. Cattaneo, C.G., and P. Carullo performed research; G.H. and J.C. contributed new reagents/analytic tools; R.P., P. Cattaneo, mark of active (or class 1) enhancers, whereas a high level of P.K., C.G., A.G., V.V., G.G.S., and G.C. analyzed data; and R.P., M.V.G.L., and G.C. wrote H3K27me3 and the absence of H3K27ac are found in “poised” the paper. (or class 2) enhancers (8). The acetyltransferase and transcrip- The authors declare no conflict of interest. tional coactivator p300/CBP binds active enhancers in several This article is a PNAS Direct Submission. tissues and organs, including heart, during development (9). 1To whom correspondence may be addressed. E-mail: roberto.papait@humanitasresearch. Recently, a large set of enhancer elements involved in regulating it or [email protected]. cardiomyocyte gene expression during differentiation in vitro This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. was identified (10). 1073/pnas.1315155110/-/DCSupplemental. 20164–20169 | PNAS | December 10, 2013 | vol. 110 | no. 50 www.pnas.org/cgi/doi/10.1073/pnas.1315155110 Downloaded by guest on October 1, 2021 Fig. 1. Genome-wide analysis of histone marks in adult cardiomyocytes isolated from pressure-overloaded and control mouse hearts. (A) Schematic of the experimental workflow. (B) Hierarchical clustering of H3K9ac (9ac), H3K27ac (27ac), H3K4me3 (4me3), H3K79me2 (79me2), H3K9me2 (9me2), H3K9me3 (9me3), and H3K27me3 (27me3) on the basis of their genomic distribution in normal (sham) and hypertrophic (TAC) cardiomyocytes. The heat map was generated with the DiffBind program. Also see Fig. S1B and Dataset S1. induces cardiac hypertrophy and then heart failure. Cardiomyocytes To obtain information on the biological role of genomic were isolated 1 wk after TAC, a time corresponding to the regions found with redistributed histone marks, we performed maximal activation of compensatory cardiac mechanisms (15, gene ontology (GO) analysis with the Genomic Regions En- 16). The purity of isolated cardiomyocytes was at least 95%, richment of Annotations Tool (21) (GREAT; default setting, 5 + as evaluated by counting the number of cells with and without 1 kb basal, up to 1 Mb extension) (Fig. S2B). The sites with the typical rod-shaped appearance (Fig. S1A). ChIP-seq was per- differential distribution of H3K9ac, H3K27ac, or H3K4me3 formed using antibodies against H3K9ac, H3K27ac, and H3K4me3, mapped preferentially to regulatory domains of genes involved in three marks associated with active regulatory regions; H3K79me2, heart function or epigenetic regulation of gene expression, a mark associated preferentially with transcribed genes (17); and whereas those with altered H3K79me2, H3K9me2, H3K9me3, or H3K9me2, H3K9me3, and H3K27me3, which are associated with H3K27me3 profiles were preferentially associated with genes repressed regions (4–7). regulating signal transduction (e.g., regulation of Rab-GTPase To identify the genomic regions undergoing a change of their activity and regulation of ARF GTPase activity) and organiza- histone mark profile on cardiac hypertrophy, we used two algo- tion and regulation of sarcomeric structure. Moreover, GO rithms, MACS (model-based analysis of ChIP-seq) (18) and SICER analysis for mouse phenotype revealed that sites with differential (spatial clustering approach for the identification of ChIP-enriched distribution of H3K9ac, H3K4me3, H3K79me2, or H3K27me3 regions) (19), to minimize the bias inherent in this procedure and were associated with hypertrophic heart phenotypes, such as compared the obtained peak datasets with DiffBind (differential thick ventricular wall, altered heart contraction, impaired skel- binding analysis of ChIP-seq peak data) (20). Hierarchical clus- etal muscle contractility, and abnormal cardiac stroke volume. tering analysis using affinity (read count) data revealed that the Together, these findings demonstrate that pressure-overload histone marks studied
Load more

Recommended publications
  • The Histone Methyltransferase DOT1L Prevents Antigen-Independent
    bioRxiv preprint doi: https://doi.org/10.1101/826255; this version posted November 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8+ T cells Eliza Mari Kwesi-Maliepaard1*, Muhammad Assad Aslam2,3*, Mir Farshid Alemdehy2*, Teun van den Brand4, Chelsea McLean1, Hanneke Vlaming1, Tibor van Welsem1, Tessy Korthout1, Cesare Lancini1, Sjoerd Hendriks1, Tomasz Ahrends5, Dieke van Dinther6, Joke M.M. den Haan6, Jannie Borst5, Elzo de Wit4, Fred van Leeuwen1,7,#, and Heinz Jacobs2,# 1Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands 2Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands 3Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, 60800 Multan, Pakistan 4Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, and Oncode Institute, The Netherlands 5Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, and Oncode Institute, The Netherlands 6Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, 1081HV Amsterdam, The Netherlands 7Department of Medical Biology, Amsterdam UMC, location AMC, UvA, 1105 AZ Amsterdam, The Netherlands * These authors contributed equally to this work. # Equal contribution and corresponding authors [email protected]; [email protected] Lead contact: Fred van Leeuwen 1 bioRxiv preprint doi: https://doi.org/10.1101/826255; this version posted November 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Genome-Wide Profiling of Active Enhancers in Colorectal Cancer
    Genome-wide proling of active enhancers in colorectal cancer Min Wu ( [email protected] ) Wuhan University https://orcid.org/0000-0003-1372-4764 Qinglan Li Wuhan University Xiang Lin Wuhan University Ya-Li Yu Zhongnan Hospital, Wuhan University Lin Chen Wuhan University Qi-Xin Hu Wuhan University Meng Chen Zhongnan Hospital, Wuhan University Nan Cao Zhongnan Hospital, Wuhan University Chen Zhao Wuhan University Chen-Yu Wang Wuhan University Cheng-Wei Huang Wuhan University Lian-Yun Li Wuhan University Mei Ye Zhongnan Hospital, Wuhan University https://orcid.org/0000-0002-9393-3680 Article Keywords: Colorectal cancer, H3K27ac, Epigenetics, Enhancer, Transcription factors Posted Date: December 10th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-119156/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Genome-wide profiling of active enhancers in colorectal cancer Qing-Lan Li1, #, Xiang Lin1, #, Ya-Li Yu2, #, Lin Chen1, #, Qi-Xin Hu1, Meng Chen2, Nan Cao2, Chen Zhao1, Chen-Yu Wang1, Cheng-Wei Huang1, Lian-Yun Li1, Mei Ye2,*, Min Wu1,* 1 Frontier Science Center for Immunology and Metabolism, Hubei Key Laboratory of Cell Homeostasis, Hubei Key Laboratory of Developmentally Originated Disease, Hubei Key Laboratory of Intestinal and Colorectal Diseases, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China 2Division of Gastroenterology, Department of Geriatrics, Hubei Clinical Centre & Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430072, China #Equal contribution to the study. Contact information *Correspondence should be addressed to Dr. Min Wu, Email: [email protected], Tel: 86-27-68756620, or Dr.
    [Show full text]
  • Histone H3K4 Demethylation Is Negatively Regulated by Histone H3 Acetylation in Saccharomyces Cerevisiae
    Histone H3K4 demethylation is negatively regulated by histone H3 acetylation in Saccharomyces cerevisiae Vicki E. Maltbya, Benjamin J. E. Martina, Julie Brind’Amourb,1, Adam T. Chruscickia,1, Kristina L. McBurneya, Julia M. Schulzec, Ian J. Johnsona, Mark Hillsd, Thomas Hentrichc, Michael S. Koborc, Matthew C. Lorinczb, and LeAnn J. Howea,2 Departments of aBiochemistry and Molecular Biology and bMedical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada V6T 1Z3; cCenter for Molecular Medicine and Therapeutics, Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4; and dTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 1L3 Edited by Kevin Struhl, Harvard Medical School, Boston, MA, and approved September 12, 2012 (received for review February 6, 2012) Histone H3 lysine 4 trimethylation (H3K4me3) is a hallmark of of lysine-specific HDMs have been identified: amine oxidases, transcription initiation, but how H3K4me3 is demethylated during such as LSD1, and the JmjC (Jumonji C) domain–containing gene repression is poorly understood. Jhd2, a JmjC domain protein, demethylases. This latter class of demethylases can be split fur- was recently identified as the major H3K4me3 histone demethylase ther into several subfamilies, including the evolutionarily con- (HDM) in Saccharomyces cerevisiae. Although JHD2 is required for served JARID1 family of demethylases, which is characterized JHD2 removal of methylation upon gene repression, deletion of does not only by a JmjC domain but also by JmjN, AT-rich interactive, not result in increased levels of H3K4me3 in bulk histones, indicating C5HC2 zinc finger, and PHD finger domains (6). In the yeast S. that this HDM is unable to demethylate histones during steady-state cerevisiae, the lone member of the JARID1 family of demethy- conditions.
    [Show full text]
  • Recognition of Histone Acetylation by the GAS41 YEATS Domain Promotes H2A.Z Deposition in Non-Small Cell Lung Cancer
    Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer Chih-Chao Hsu,1,2,8 Jiejun Shi,3,8 Chao Yuan,1,2,7,8 Dan Zhao,4,5,8 Shiming Jiang,1,2 Jie Lyu,3 Xiaolu Wang,1,2 Haitao Li,4,5 Hong Wen,1,2 Wei Li,3 and Xiaobing Shi1,2,6 1Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; 2Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; 3Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; 4MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China; 5Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China; 6Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030, USA Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Re- cently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine- binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias.
    [Show full text]
  • H3K27 Acetylation and Gene Expression Analysis Reveals Differences in Placental Chromatin Activity in Fetal Growth Restriction N
    Paauw et al. Clinical Epigenetics (2018) 10:85 https://doi.org/10.1186/s13148-018-0508-x RESEARCH Open Access H3K27 acetylation and gene expression analysis reveals differences in placental chromatin activity in fetal growth restriction N. D. Paauw1,6*, A. T. Lely1, J. A. Joles2, A. Franx1, P. G. Nikkels3, M. Mokry4 and B. B. van Rijn1,5,6* Abstract Background: Posttranslational modification of histone tails such as histone 3 lysine 27 acetylation (H3K27ac) is tightly coupled to epigenetic regulation of gene expression. To explore whether this is involved in placenta pathology, we probed genome-wide H3K27ac occupancy by chromatin immunoprecipitation sequencing (ChIP- seq) in healthy placentas and placentas from pathological pregnancies with fetal growth restriction (FGR). Furthermore, we related specific acetylation profiles of FGR placentas to gene expression changes. Results: Analysis of H3K27ac occupancy in FGR compared to healthy placentas showed 970 differentially acetylated regions distributed throughout the genome. Principal component analysis and hierarchical clustering revealed complete segregation of the FGR and control group. Next, we identified 569 upregulated genes and 521 downregulated genes in FGR placentas by RNA sequencing. Differential gene transcription largely corresponded to expected direction based on H3K27ac status. Pathway analysis on upregulated transcripts originating from hyperacetylated sites revealed genes related to the HIF-1-alpha transcription factor network and several other genes with known involvement in placental pathology (LEP, FLT1, HK2, ENG, FOS). Downregulated transcripts in the vicinity of hypoacetylated sites were related to the immune system and growth hormone receptor signaling. Additionally, we found enrichment of 141 transcription factor binding motifs within differentially acetylated regions.
    [Show full text]
  • Investigation of KRAS Dependency Bypass and Functional Characterization of All Possible KRAS Missense Variants
    Investigation of KRAS Dependency Bypass and Functional Characterization of All Possible KRAS Missense Variants The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:40050098 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Investigation of KRAS Dependency Bypass and Functional Characterization of All Possible KRAS Missense Variants A dissertation presented by Seav Huong Ly to The Division of Medical Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Biological and Biomedical Sciences Harvard University Cambridge, Massachusetts April 2018 © 2018 Seav Huong Ly All rights reserved. Dissertation Advisor: William C. Hahn Seav Huong Ly Investigation of KRAS Dependency Bypass and Functional Characterization of All Possible KRAS Missense Variants Abstract The importance of oncogenic KRAS in human cancers have prompted intense efforts to target KRAS and its effectors. To anticipate the development of resistance to these strategies, we previously performed a genome-scale expression screen to identify genes that bypass KRAS oncogenic dependency. Here we test thirty-seven genes that scored over five standard deviations and find that overexpression of LIM homeobox 9 (LHX9), a transcription factor involved in embryonic development, robustly rescues the suppression of KRAS in vitro and xenograft models. Furthermore, LHX9 substantially decreases cell sensitivity to KRASG12C and MEK1/2 inhibitors in KRAS-dependent cells.
    [Show full text]
  • Deciphering the Histone Code to Build the Genome Structure
    bioRxiv preprint doi: https://doi.org/10.1101/217190; this version posted November 20, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Deciphering the histone code to build the genome structure Kirti Prakasha,b,c,* and David Fournierd,* aPhysico-Chimie Curie, Institut Curie, CNRS UMR 168, 75005 Paris, France; bOxford Nanoimaging Ltd, OX1 1JD, Oxford, UK; cMicron Advanced Bioimaging Unit, Department of Biochemistry, University of Oxford, Oxford, UK; dFaculty of Biology and Center for Computational Sciences, Johannes Gutenberg University Mainz, 55128 Mainz, Germany; *Correspondence: [email protected], [email protected] Histones are punctuated with small chemical modifications that alter their interaction with DNA. One attractive hypothesis stipulates that certain combinations of these histone modifications may function, alone or together, as a part of a predictive histone code to provide ground rules for chromatin folding. We consider four features that relate histone modifications to chromatin folding: charge neutrali- sation, molecular specificity, robustness and evolvability. Next, we present evidence for the association among different histone modi- fications at various levels of chromatin organisation and show how these relationships relate to function such as transcription, replica- tion and cell division. Finally, we propose a model where the histone code can set critical checkpoints for chromatin to fold reversibly be- tween different orders of the organisation in response to a biological stimulus. DNA | nucleosomes | histone modifications | chromatin domains | chro- mosomes | histone code | chromatin folding | genome structure Introduction The genetic information within chromosomes of eukaryotes is packaged into chromatin, a long and folded polymer of double-stranded DNA, histones and other structural and non- structural proteins.
    [Show full text]
  • The Diverse Functions of Dot1 and H3K79 Methylation
    Downloaded from genesdev.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The diverse functions of Dot1 and H3K79 methylation Anh Tram Nguyen1,2 and Yi Zhang1,2,3 1Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA; 2Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA DOT1 (disruptor of telomeric silencing; also called ute to transcriptional regulation is to serve as a platform Kmt4) was initially discovered in budding yeast in a genetic for the recruitment of effector proteins. The well-studied screen for genes whose deletion confers defects in telo- lysine methylation residues include K4, K9, K27, K36, meric silencing. Since the discovery ~10 years ago that and K79 of histone H3, and K20 of histone H4. In general, Dot1 and its mammalian homolog, DOT1L (DOT1-Like), methylation at H3K9, H3K27, and H4K20 correlates with possess histone methyltransferase activity toward histone transcriptional repression, while methylation at H3K4, H3 Lys 79, great progress has been made in characterizing H3K36, and H3K79 correlates with gene transcription their enzymatic activities and the role of Dot1/DOT1L- (Kouzarides 2002; Peterson and Laniel 2004; Martin and mediated H3K79 methylation in transcriptional regula- Zhang 2005). In addition to its role in transcriptional tion, cell cycle regulation, and the DNA damage response. regulation, methylation has also been linked to X inacti- In addition, gene disruption in mice has revealed that vation, cell fate determination, terminal differentiation, mouse DOT1L plays an essential role in embryonic de- and the spatiotemporal patterning of Hox genes (Cavalli velopment, hematopoiesis, cardiac function, and the de- 2006; Minard et al.
    [Show full text]
  • Dynamics of Transcription-Dependent H3k36me3 Marking by the SETD2:IWS1:SPT6 Ternary Complex
    bioRxiv preprint doi: https://doi.org/10.1101/636084; this version posted May 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dynamics of transcription-dependent H3K36me3 marking by the SETD2:IWS1:SPT6 ternary complex Katerina Cermakova1, Eric A. Smith1, Vaclav Veverka2, H. Courtney Hodges1,3,4,* 1 Department of Molecular & Cellular Biology, Center for Precision Environmental Health, and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA 2 Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic 3 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA 4 Department of Bioengineering, Rice University, Houston, TX, 77005, USA * Lead contact; Correspondence to: [email protected] Abstract The genome-wide distribution of H3K36me3 is maintained SETD2 contributes to gene expression by marking gene through various mechanisms. In human cells, H3K36 is bodies with H3K36me3, which is thought to assist in the mono- and di-methylated by eight distinct histone concentration of transcription machinery at the small portion methyltransferases; however, the predominant writer of the of the coding genome. Despite extensive genome-wide data trimethyl mark on H3K36 is SETD21,11,12. Interestingly, revealing the precise localization of H3K36me3 over gene SETD2 is a major tumor suppressor in clear cell renal cell bodies, the physical basis for the accumulation, carcinoma13, breast cancer14, bladder cancer15, and acute maintenance, and sharp borders of H3K36me3 over these lymphoblastic leukemias16–18. In these settings, mutations sites remains rudimentary.
    [Show full text]
  • EZH2 in Normal Hematopoiesis and Hematological Malignancies
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 3 EZH2 in normal hematopoiesis and hematological malignancies Laurie Herviou2, Giacomo Cavalli2, Guillaume Cartron3,4, Bernard Klein1,2,3 and Jérôme Moreaux1,2,3 1 Department of Biological Hematology, CHU Montpellier, Montpellier, France 2 Institute of Human Genetics, CNRS UPR1142, Montpellier, France 3 University of Montpellier 1, UFR de Médecine, Montpellier, France 4 Department of Clinical Hematology, CHU Montpellier, Montpellier, France Correspondence to: Jérôme Moreaux, email: [email protected] Keywords: hematological malignancies, EZH2, Polycomb complex, therapeutic target Received: August 07, 2015 Accepted: October 14, 2015 Published: October 20, 2015 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2, inhibits gene expression through methylation on lysine 27 of histone H3. EZH2 regulates normal hematopoietic stem cell self-renewal and differentiation. EZH2 also controls normal B cell differentiation. EZH2 deregulation has been described in many cancer types including hematological malignancies. Specific small molecules have been recently developed to exploit the oncogenic addiction of tumor cells to EZH2. Their therapeutic potential is currently under evaluation. This review summarizes the roles of EZH2 in normal and pathologic hematological processes and recent advances in the development of EZH2 inhibitors for the personalized treatment of patients with hematological malignancies. PHYSIOLOGICAL FUNCTIONS OF EZH2 state through tri-methylation of lysine 27 on histone H3 (H3K27me3) [6].
    [Show full text]
  • 16-0368 Technical Data Sheet
    Nucleosome, Recombinant Human, H3K79me2 dNuc, Biotinylated Catalog No. 16-0368 Lot No. 19045001 Pack Size 50 µg Product Description: 1 2 Mononucleosomes assembled from recombinant human histones expressed in E. coli (two each of histones H2A, H2B, H3 and H4; accession numbers: H2A-P04908; H2B- O60814; H3.1-P68431; H4-P62805) wrapped by 147 base pairs of 601 positioning sequence DNA. Histone H3 (created by a proprietary synthetic method) contains dimethyl-lysine at position 79. The nucleosome is the basic subunit of chromatin. The 601 sequence, identified by Lowary and Widom, is a 147-base pair sequece that has high affinity for histone octamers and is useful for nucleosome assembly and contains a 5’ biotin-TEG group. Western Blot Data: Western Analysis of Nucleosome, Recombinant Human, H3K79me2. Top Panel: Unmodified H3 Formulation: (Lane 1) and H3K79me2 containing nucleosomes (Lane 2) were Nucleosome, Recombinant Human, H3K79me2 (27.3 µg probed with an anti-H3K79me2 antibody and analyzed via ECL protein weight, 50 µg total weight) in µl of 10 mM Tris readout. Only the H3K79me2sample produced a detectable signal. HCl, pH 7.5, 25 mM NaCl, 1 mM EDTA, 2 mM DTT, 20% Bottom Panel: Detailfrom Coomassie stained gel showing glycerol. unmodified nucleosomes (Lane 1) and H3K79me2 nucleosomes Molarity = μmolar. MW = Da. (Lane 2). Storage and Stability: Stable for six months at -80°C from date of receipt. For best results, aliquot and avoid multiple freeze/thaws. Application Notes: Nucleosome, Recombinant Human, H3K79me2 dNucs are highly purified and are suitable for use as substrates in enzyme screening assays or for effector protein binding experiments.
    [Show full text]
  • Le G´Enome En Action
    LEGENOME´ EN ACTION SEQUENC´ ¸ AGE HAUT DEBIT´ ET EPIG´ ENOMIQUE´ Epig´enomique´ ? IFT6299 H2014 ? UdeM ? Mikl´osCs}ur¨os Regulation´ d’expression la transcription d’une region´ de l’ADN necessite´ ? liaisons proteine-ADN´ (facteur de transcription et son site reconnu) ? accessibilite´ de la chromatine REVIEWS Identification of regions that control transcription An initial step in the analysis of any gene is the identifi- cation of larger regions that might harbour regulatory control elements. Several advances have facilitated the prediction of such regions in the absence of knowl- edge about the specific characteristics of individual cis- Chromatin regulatory elements. These tools broadly fall into two categories: promoter (transcription start site; TSS) and enhancer detection. The methods are influenced Distal TFBS by sequence conservation between ORTHOLOGOUS genes (PHYLOGENETIC FOOTPRINTING), nucleotide composition and the assessment of available transcript data. Functional regulatory regions that control transcrip- tion rates tend to be proximal to the initiation site(s) of transcription. Although there is some circularity in the Co-activator complex data-collection process (regulatory sequences are sought near TSSs and are therefore found most often in these regions), the current set of laboratory-annotated regula- tory sequences indicates that sequences near a TSS are Transcription more likely to contain functionally important regulatory initiation complex Transcription controls than those that are more distal. However, specifi- initiation cation of the position of a TSS can be difficult. This is fur- ther complicated by the growing number of genes that CRM Proximal TFBS selectively use alternative start sites in certain contexts. Underlying most algorithms for promoter prediction is a Figure 1 | Components of transcriptional regulation.
    [Show full text]